Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor - sparing strategy: Results from the multicenter study with nevirapine and kaletra (MULTTNEKA)

1. Negredo, E.
2. Miró, O.
3. Rodríguez-Santiago, B.
4. Garrabou, G.
5. Estany, C.
6. Masabeu, A.
7. Force, L.
8. Barrufet, P.
9. Cucurull, J.
10. Domingo, P.
11. Alonso-Villaverde, C.
12. Bonjoch, A.
13. Morón, C.
14. Pérez-Álvarez, N.
15. Clotet, B.
16. Alonso, A.
17. Boix, V.
18. Cartón, J.A.
19. de la Torre, J.
20. Echevarría, S.
21. Galindo, M.J.
22. Gutiérrez, F.
23. Roca, V.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1086/605440 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus